NAFLD

September 16, 2017

Molecular therapy for Non-alcoholic fatty liver disease (NAFLD): Oleic acid, isolated from Olive oil, sunflower oil and among others, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 16/September/2017, 11.20 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while only 6-25% of Asian populations suffer from it; […]
September 13, 2017

Molecular therapy for Non-alcoholic fatty liver disease (NAFLD): Ursodeoxycholic acid (UDCA) [Trade name: Actigall, Udcasid] promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 12/September/2017, 9.49 am

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while only 6-25% of Asian populations suffer from it; […]
September 9, 2017

Steroid-based therapy for Non-alcoholic fatty liver disease (NAFLD): Prostaglandin(PGE2) promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 9/September/2017, 12/25 am

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while only 6-25% of Asian populations suffer from it; […]
September 8, 2017

Natural product therapy for Non-alcoholic fatty liver disease (NAFLD): Kaempferol, a flavonoid isolated from Aloe vera, among others, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 8/September/2017, 11.52 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]